Injective (INJ) Recovers 7.6% to $13.31 Following EVM Upgrade and ETF Filing

INJ rebounds to $13.31 after recent consolidation, as Cboe's staked ETF filing and Ethernia Upgrade provide fundamental catalysts despite short-term profit-taking pressure.